节点文献

活血益脉胶囊治疗高粘血症的临床研究

【作者】 吴登山

【导师】 邹忆怀;

【作者基本信息】 北京中医药大学 , 中医内科学, 2003, 硕士

【摘要】 活血益脉胶囊是由著名老中医高辉远教授经60年治疗血栓性疾病的经验而配制的纯中药的胶囊制剂。它的主要成分为水蛭、川芎、红花。具有破血逐瘀,疏通经脉的作用,适用于高粘血症的病人。高粘血症是血流阻力增加,血流缓慢,组织灌注减少,导致组织缺氧,红细胞变形能力降低,血小板聚集增加,纤维蛋白原增高,甚至形成血栓,属于中医的“血瘀”范畴。主要见于中老年人及其相关疾病,临床症状或有或无。有时出现头痛、头晕,肢体麻木不仁、乏力,甚至反应迟钝,或胸痛、胸闷、憋气、心慌、气短、心悸、喘促等症状,舌质暗或暗红,有瘀点或瘀斑,脉弦或迟或涩,一般伴有血液流变学或凝血系列的异常,可根据这些症状及理化检查判断为高粘血症[7]。高粘血症也可表现为无明显的临床症状,只是有舌质暗红、或紫暗、或有瘀点、瘀斑,但血流变学及凝血系列,心电图,或血脂检查的部分指标异常,也可作为高粘血症的辨证依据。现在一般的共识是凡45岁以上,血液流变学测定或凝血系列的部分指标异常者,或者舌质的暗红、暗,瘀点、瘀斑,或有心电图ST段改变或T波改变,或颅内多普勒检查提示脑动脉供血不足的改变,或表现为头痛、头晕,肢体麻木,反应迟钝,或胸痛、憋气、心慌气短、心悸、喘促,或脉涩、脉弦、脉结、代等,均可辩证为高粘血症。是“血凝而不流”,“血泣则不通”,虽然中医病机错综复杂,但瘀血痰浊阻络,瘀滞粘凝不通是其本质,这也是血液流变学检测的“浓、聚、粘、凝、瘀”的状态。水蛭性猛而力峻,为破血逐瘀之良药。《本草纲目》记载:“水蛭味咸平,主逐恶血,瘀血,月闭,破血瘕积聚。”,高老认为水蛭用生粉效果更佳,且在活血益脉胶囊中,水蛭为君药,量大,含量多。因为经煎煮容易破坏水蛭的有效成分水蛭素,肝素等抗血栓物质。活血益脉胶囊能有效的降低全血粘度,纤维蛋白原、血浆粘度,降低血小板聚集率,降低胆固醇及甘油三酯,延长凝血酶原时间,延长部分凝血活酶时间,改善血液流变性,增加器官的供血。目的:为了进一步研究活血益脉胶囊治疗高粘血症的治疗作用,深入探讨其作用机理。方法:通过文献综述总结了高粘血症的定义、形成,临床症状及理化指标,同时展示了临床利用中药、中成药、中西医结合治疗高粘血症的经验,以及各种治疗方法对血流变学、血凝系列、血脂系列,血栓三项的影响。同时也归纳了近年来水蛭、川芎、红花治疗高粘血症的相关药理研究结果,提示了活血化瘀,破血逐瘀,疏通经脉对于治疗高粘血症,心脑血管病的作用机理具有较大的意义。临床研究方面,采用随机原则,以活血益脉胶囊为治疗组,以复方丹参片为对照组,对54例高粘血症的病人进行了观察,结果表明:治疗组30例病人,总有疗效率93.3%,总显效率为56.7%,24例复方丹参片对照组,总有效率为75.0%,总显效率为37.5%,治疗组疗效优于对照组(P<0.05),说明了活血益脉胶囊治疗高粘血症有显著疗效,在临床症状,舌质、脉象方面,经综合疗效评定,.治疗组也优于对照组。但年龄不同,疗效无显著性差异P>0.05,疗效与疗程也无显著性差异。服药1-6个月,疗效基本稳定。结果:从理化指标看,对于血液流变学,活血益脉胶囊组与复方丹参片组均可降低全血浓度,全血低切还原粘度,但治疗组明显降低血浆粘度,红细胞压积等,在降低全血低切,高切还原粘度方面,较对照组更为显著(P<0.05)。治疗组在降低胆固醇(TC),甘油酯(TG),低密度脂蛋白(LDC-C),升高高密度脂蛋白方面(HDL-C),治疗前后有显著性差异(P<0.05),而对照组治疗前后差异不显著(P>0.05)。在血栓三项检测中,治疗组对血浆血小板颗粒膜蛋白(GMP-140),血栓素(TXB2)前列环素(6-keto-pgf1α)治疗前后有显著性差异(P<0.05,p<0.01),而对照组治疗前后差异不显著(P>0.05),同样治疗组对凝血系列的纤维蛋白原,凝血活酶(PT),部分凝血活酶时间(APTT),治疗前后差异显著(P<0.01),而对照组差异不显著(P>0.05)。 结论:以上研究结果表明活血益脉胶囊通过降低血粘度,降低甘油三酯,胆固醇,升高高密度脂蛋白,延长凝血酶原时间,和部分凝血活酶时间,抑制血浆血小板颗粒膜蛋白和血栓素的释放和形成,促进前列环素的生成和增加,从而改善临床症状,发挥破血逐瘀的作用来治疗高粘血症。

【Abstract】 The research includes literature summarization and clinical study.Huo Xue Yi Mai Capsule, which has the function of curing blood stasis in TCM is a new kind of medicine in curing blood hyperviscosity syndromes (BHS). This capsule is provided by the famous traditional Chinese medicine doctor Gao Hui Yuan professor who had cured a lot of patients with blood stasis during sixty years. It has remarkable curative effects on patients who have the blood hyperviscosity syndromes. We found the curing mechanism related to the function of restrain the activation of platelet. To make further researches. We have finished the work as that.with Huo Xue Yi Mai capsule as therapeutic group,24 patients with Fu Fang Dan Shen capsule as contrast group. The changer of the symptoms mark before and after treatment was observed in the patients of BHS. The result showed that the symptoms mark of the observation patients became lower that before. The effective rate of therapeutic group was 93.3%,and the contrast was 75%.There was obviously different of the curative effect from the two group(P<0.05).The BHS mark was also observed and had a obviously reduction after the treatment with Huo Xue Yi Mai capsule. It showed that this capsule can change the state of BHS with the function of removing blood static.The change of the GMP-140 and TXB2 in plasma before and after the treatment with Huo Xue Yi Mai capsule was observed in the patients of BHS. The result shows that the level of GMP-140 and TXB2 became lower than before. It shows that the level of 6-keto-pGf became higher than before.(P<0.05) At the same time , It shows that the level of the velocity of blood flow and the fibrinogen plasma lipid cut down. Huo Xue Yi Mai capsule can restraint the activation of BHS to remove blood stasis and treating BHS. The improvement of hemorheology and the change of PT and APTT after the treatment with Huo Xue Yi Mai capsule were significant. Further more, side-effect was not. Conclusion: Huo Xue Yi Mai capsule is a good medicine in treating patients with BHS. At least in the near future effects, and there are few adverse events. So it is a safe therapeutic medicine.

  • 【分类号】R259.8
  • 【下载频次】148
节点文献中: 

本文链接的文献网络图示:

本文的引文网络